phrykt

Organon & Co. (OGN): who owns it and who trades it

As of Nov 16, 2026, OGN insiders reported 2 open-market sales worth $553K and 1 purchase worth $353K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Lynette Holzbaur (Vice president), with $353K. 3 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Organon

From the latest filings

Overall: more selling than buying. Insiders and Congress mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns OGN

622 funds and institutions reported OGN shares worth $3B at the end of Q2 2026, about 84% of the company. The largest holder is BlackRock, Inc. with 12.2%.

Funds and institutions (13F) 84%Everyone else 16%

10 largest owners, by share of the company

BlackRock, Inc.12.2%
Pentwater Capital Management LP6.9%
Vanguard Portfolio Management LLC5.8%
Vanguard Capital Management LLC4.5%
State Street Corp3.7%
Goldman Sachs Group Inc2.0%
UBS Group AG1.8%
Geode Capital Management, LLC1.8%
Alliancebernstein L.P.1.8%
Man Group plc1.6%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.32.06M12.21%$434M+1%
Pentwater Capital Management LP18.10M6.89%$245M–
Vanguard Portfolio Management LLC15.13M5.76%$205M-31%
Vanguard Capital Management LLC11.91M4.54%$161M+1%
State Street Corp9.66M3.68%$131M-3%
Goldman Sachs Group Inc5.20M1.98%$70.4M+224%
UBS Group AG4.86M1.85%$65.8M+40%
Geode Capital Management, LLC4.82M1.83%$65.2M+1%
Alliancebernstein L.P.4.75M1.81%$28.5M+560%
Man Group plc4.18M1.59%$56.6M–
AQR Arbitrage LLC3.88M1.48%$52.4M–
Private Management Group Inc3.74M1.43%$50.7M-14%
Lsv Asset Management3.74M1.42%$50.6M-49%
Charles Schwab Investment Management Inc3.46M1.32%$46.8M+3%
Sixth Street Partners Management Company, L.P.3.46M1.32%$46.8M–
Millennium Management LLC3.44M1.31%$46.6M-49%
Dimensional Fund Advisors LP3.27M1.24%$44.2MNo change
First Trust Advisors LP3.10M1.18%$42M-4%
Capula Management Ltd3.05M1.16%$41.3M–
Nexpoint Asset Management, L.P.3.01M1.15%$40.8M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, OGN insiders reported $353K of open-market purchases and $553K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$353K
1 trades, 1 people
Sales, 12 months
$553K
2 trades, 2 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Aug 5, 2026
Filed Aug 5, 2026

Purchases and sales by month

$353K$353KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 5, 2026Juliana Papa DrinaneHead of Mfg & SupplySale14,761$13.57$200KForm 4
May 6, 2026Lynette HolzbaurVice presidentSale26,448$13.35$353KForm 4
May 6, 2026Lynette HolzbaurVice presidentPurchase26,448$13.35$353KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Lynette HolzbaurSVP and Corporate Controller$353K$353KMay 6, 2026
Juliana Papa DrinaneHead of Mfg & Supply–$200KAug 5, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

OGN short interest

Moderate short interest. 7.5% of OGN shares are sold short: about 1 share in 13. Over the last 12 reports the number of shares short went down 2%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 19.69M OGN shares were sold short, 7.5% of the shares outstanding, up 4.7% from the report before. At the average daily volume of 2.32M shares, buying them all back would take about 8.5 trading days (days to cover).

Shares short, % of all shares

7.50%May 15Oct 307.91%

Days to cover

8.5May 15Oct 309.9

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202619.69M7.50%+5%2.32M8.5
Oct 15, 202618.82M7.17%-1%2.18M8.6
Sep 30, 202618.96M7.22%+8%2.09M9.1
Sep 15, 202617.53M6.68%+5%3.17M5.5
Aug 31, 202616.70M6.36%+10%3.26M5.1
Aug 14, 202615.14M5.76%-10%2.48M6.1
Jul 31, 202616.81M6.40%+3%2.71M6.2
Jul 15, 202616.24M6.19%-5%2.55M6.4
Jun 30, 202617.09M6.51%-10%2.47M6.9
Jun 15, 202619.01M7.24%+5%2.42M7.9
May 29, 202618.07M6.88%-10%3.29M5.5
May 15, 202620.04M7.63%+3%6.33M3.2

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded OGN

Since Nov 17, 2024, 2 members of Congress reported 0 purchases and 2 sales of OGN. The latest was a sale by Kevin Hern on Aug 5, 2026, reported Aug 10, 2026.

Purchases 0Sales 2

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Aug 5, 2026Kevin Hern (R-OK)Sale$1K–$15KJointAug 10, 2026Report
Jul 10, 2025Gary C. Peters (D-MI)Sale$1K–$15KSelfNov 24, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

Organon company events

Organon filed 9 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Oct 30, 2026.

  1. Oct 30, 2026AnnouncementShared information with investors. Filing
  2. Jul 31, 2026AnnouncementShared information with investors. Filing
  3. Jul 23, 2026VoteReported shareholder vote results. Filing
  4. Jul 17, 2026AnnouncementAs previously disclosed, on April 26, 2026, Organon & Co., a Delaware corporation, entered into an Agreement and Plan of Merger by and among the Company, Sun Pharmaceutical Holdings USA, Inc., and Sun Pharma America, Inc., a wholly owned subsidiary of Sun Pharma USA, and, solely for purposes of… Filing
  5. Jun 11, 2026LeadershipDeparture of Directors or Certain Officers; Election of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Filing
  6. Apr 30, 2026ResultsReleased financial results. Filing
  7. Apr 27, 2026LeadershipAppointment of Chief Executive Officer As previously disclosed in a Current Report on Form 8-K filed by the Company on October 27, 2025, on October 26, 2025, Joseph Morrissey was appointed Interim Chief Executive Officer (and principal executive officer) of the Company. Filing
  8. Feb 20, 2026AnnouncementAs previously disclosed on February 12, 2026, the Audit Committee of the Board of Directors of Organon & Co. conducted an independent review of the information brought to the Audit Committee’s attention on February 11, 2026 relating to the timing of the Company’s purchases of biosimilars from a… Filing
  9. Feb 12, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Organon financials

Famous investors that hold OGN

3 of the 50 well-known investors we track reported holding OGN in their latest 13F filing. The largest position is Israel Englander's, worth $70.4M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 20265.14M$70.4M0.1%+49%
George Soros · Soros Fund ManagementQ3 20262.95M$40.5M0.8%New
Ken Griffin · Citadel AdvisorsQ3 2026125,162$1.7M0.0%-64%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Organon & Co. (OGN) stock

Who owns the most OGN stock?

The largest reported owner of Organon & Co. (OGN) is BlackRock, Inc., with 12.2% of the company. In total, 622 funds and institutions reported holding OGN at the end of Q2 2026, together about 84% of the shares. See the largest owners.

Are OGN insiders buying or selling?

In the last 12 months, OGN insiders reported 1 open-market purchase worth $353K and 2 sales worth $553K. The latest trade was on Aug 5, 2026. See every trade.

What is the short interest in OGN?

As of Oct 30, 2026, 19.69M OGN shares were sold short, 7.5% of the shares outstanding, up 4.7% from the report before. At the average daily volume of 2.32M shares, buying them all back would take about 8.5 trading days (days to cover). See the history.

Have members of Congress traded OGN?

Yes. 2 members of Congress reported 0 purchases and 2 sales of OGN since Nov 17, 2024. The latest was reported on Aug 10, 2026. See the trades.

Which famous investors hold OGN?

3 of the 50 well-known investors we track reported OGN in their latest 13F filing, including Israel Englander, George Soros, Ken Griffin. The largest position is worth $70.4M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.